(Q50975750)

26 March 2018

title

Nicardipine as antihypertensive therapy in liver transplant recipients: results of long-term use. (English)

1 reference

26 March 2018

1 reference

Duvoux C

1

1 reference

26 March 2018

Cherqui D

2

1 reference

26 March 2018

Di Martino V

3

1 reference

26 March 2018

Métreau JM

4

1 reference

26 March 2018

Salvat A

5

1 reference

26 March 2018

Lauzet JY

6

1 reference

26 March 2018

Fagniez PL

7

1 reference

26 March 2018

Dhumeaux D

8

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

26 March 2018

published in

Hepatology

1 reference

26 March 2018

volume

25

1 reference

26 March 2018

issue

2

1 reference

26 March 2018

page(s)

430-433

1 reference

26 March 2018

Liver transplantation (2).

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

Clinical pharmacology of nicardipine in liver transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

Cyclosporin-verapamil interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

An analysis of cyclosporine efficacy and toxicity after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Beyond 1 year after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

De novo hypertension after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. IV Nicardipine Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Nicardipine increases cyclosporin blood levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Ciclosporin-nicardipine interaction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Diltiazem in renal allograft recipients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Verapamil inhibits cyclosporin metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Increased cyclosporine blood concentrations due to verapamil administration.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Cyclosporin metabolism in human liver microsomes and its inhibition by other drugs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510250229

7 January 2021

Identifiers

DOI

10.1002/HEP.510250229

1 reference

26 March 2018

1 reference

26 March 2018